NASDAQ / LIVE COMPANY INTELLIGENCE

Adicet Bio, Inc.

Nasdaq-listed company. Follow earnings, filings, products, capital and the competitive forces moving the company.

TICKERACET
CORENasdaq-listed company
WATCHEarnings + filings + operating news
STATUSContinuously updated
LIVE / ACET COVERAGE

What’s moving Adicet Bio, Inc. now

Current reporting with the operating signal separated from the noise.

01
Adicet Bio, Inc. (ACET) ADI-001 Phase 1 Clinical Update Call Transcript

Adicet Bio, Inc. (ACET) ADI-001 Phase 1 Clinical Update Call Transcript

The story matters when it changes Adicet Bio, Inc.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
02
Adicet Bio, Inc. Announces Pricing of Public Offering

Adicet Bio, Inc. Announces Pricing of Public Offering

The story matters when it changes Adicet Bio, Inc.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
03
Adicet Bio, Inc. (ACET) Reports Q3 Loss, Lags Revenue Estimates

Adicet Bio, Inc. (ACET) Reports Q3 Loss, Lags Revenue Estimates

Investors are testing whether Adicet Bio, Inc.’s operating performance supports its strategy and valuation.

Watch next: the filing, cash flow, guidance and capital-expenditure plan.
04
Adicet Bio, Inc. Announces Pricing of $135 Million Public Offering of Common Stock and Concurrent Private Placement

Adicet Bio, Inc. Announces Pricing of $135 Million Public Offering of Common Stock and Concurrent Private Placement

Investors are testing whether Adicet Bio, Inc.’s operating performance supports its strategy and valuation.

Watch next: the filing, cash flow, guidance and capital-expenditure plan.
05
Adicet Bio, Inc. Announces Proposed Public Offering of Common Stock and Concurrent Private Placement

Adicet Bio, Inc. Announces Proposed Public Offering of Common Stock and Concurrent Private Placement

Investors are testing whether Adicet Bio, Inc.’s operating performance supports its strategy and valuation.

Watch next: the filing, cash flow, guidance and capital-expenditure plan.
PRIMARY DOCUMENTS / SEC EDGAR

Latest ACET filings.

Investor-relevant reports are shown first, followed by the company’s other recent official submissions.

10-QQuarterly financial reportFiled 2026-05-13 · Period 2026-03-31SEC ↗10-QQuarterly financial reportFiled 2025-11-05 · Period 2025-09-30SEC ↗10-K/AAnnual financial reportFiled 2026-05-20 · Period 2025-12-31SEC ↗8-KMaterial company eventFiled 2026-06-18 · Period 2026-06-17SEC ↗8-KMaterial company eventFiled 2026-05-13 · Period 2026-05-13SEC ↗8-KMaterial company eventFiled 2026-04-28 · Period 2026-04-27SEC ↗DEF 14AProxy and shareholder meetingFiled 2026-04-29 · Period 2026-04-29SEC ↗4Official SEC filingFiled 2026-06-23 · Period 2026-06-19SEC ↗
EARNINGS / QUARTERLY TRACKER

Adicet Bio, Inc., quarter by quarter.

Results, guidance and earnings coverage are grouped only when the source headline identifies the reporting period.